Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diffusion Length of Ropivacaine in Subparaneural Sciatic Block
NCT05437835Unknown
- Sponsor
- General Hospital of Ningxia Medical University
- Start
- Jul 2022
- Primary completion
- Jul 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Single-blind, single-arm trial of ropivacaine in postoperative pain, sponsored by General Hospital of Ningxia Medical University. Primary endpoints: Correlation between the diffusion length of local anesthetics in the subparaneural space and the duration of analgesia at 3 days and Minimum effective diffusion length of local anesthetics in the subparaneural space at 30 minutes. Status: unknown.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05437835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05437835.